Hochdorf Swiss Nutrition has named Sandro Tichelli as its next chief executive, with the leadership change set to take effect at the start of 2026.
Tichelli will replace Ralph Siegl, who has led the Switzerland-based infant formula and dairy ingredients producer since 2022.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
In a statement, the company’s board of directors thanked Siegl for steering Hochdorf through its separation from the former parent company and its sale to AS Equity Partners in 2024.
Tichelli previously held management roles at Danone in Switzerland and Germany, most recently working as country manager for Switzerland and sitting on the DACH region executive board.
Until Tichelli assumes the role, Oliver Banz will act as interim chief executive.
Banz is a partner and head of portfolio management at AS Equity Partners, and has a background as a lawyer and management consultant at McKinsey.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataOn Tichelli’s appointment, the board of directors said: “Following the completion of this transition phase, we want to lead Hochdorf to renewed international growth. We are confident that Sandro Tichelli, with his dynamic personality, extensive management experience and deep understanding of the international food market, is the ideal CEO to achieve this.”
Tichelli added: “The company has excellent products, strong brands and great potential. Together with our team, we will drive growth and consolidate Hochdorf’s position as a leading global provider of nutritional solutions.”
Established in 1895, Hochdorf specialises in milk-based products for infants and young children, as well as other milk powders and nutritional supplements. Its brands include Bimbosan.
The company, which acted as the manufacturing arm of Hochdorf Holding, was effectively put up for sale in April 2024 following an announcement of a strategic review for the struggling business.
Hochdorf Holding began reassessing its strategy in 2019 after a series of profit warnings, subsequently divesting its majority interest in baby-food business Pharmalys and exiting product areas including cooking oils, flour, cereals, snacks, and fruit and vegetables.
